Alterity Therapeutics

(OTC) PRNAF

Current Price$0.00

Market Cap$11.96M

Since IPO (2003)-100%

5 Year-95%

1 Year-89%

1 Month-89%

Alterity Therapeutics Financials at a Glance

Market Cap

$11.96M

Revenue (TTM)

A$5.64M

Net Income (TTM)

-A$44.51M

EPS (TTM)

-$0.00

P/E Ratio

-1.10

Dividend

$0.00

Beta (Volatility)

1.54 (High)

Dividend

$0.00

Beta (Volatility)

1.54 (High)

Price

$0.00

Volume

5,000

Open

$0.00

Price

$0.00

Volume

5,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Dividend

$0.00

Beta (Volatility)

1.54 (High)

Price

$0.00

Volume

5,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

PRNAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Alterity Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David A. Stamler, MD

Website

www.alteritytherapeutics.com

Headquarters

Melbourne, VIC 3000, AU

PRNAF Financials

Key Financial Metrics (TTM)

Gross Margin

97%

Operating Margin

-5%

Net Income Margin

-4%

Return on Equity

-46%

Return on Capital

-37%

Return on Assets

-26%

Earnings Yield

-90.91%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.96M

Shares Outstanding

10.88B

Volume

5.00K

Avg. Volume

9.12K

Financials (TTM)

Gross Profit

A$5.31M

Operating Income

-A$14.57M

EBITDA

-A$14.63M

Operating Cash Flow

-A$11.45M

Capital Expenditure

A$0.00

Free Cash Flow

-A$11.45M

Cash & ST Invst.

A$40.66M

Total Debt

A$155.46K

Alterity Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$57.87K

-103.2%

Gross Margin

0.00%

N/A

Market Cap

$11.96M

N/A

Market Cap/Employee

$1.20M

N/A

Employees

N/A

Net Income

-A$9.61M

-257.3%

EBITDA

-A$12.99M

-96.8%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

A$49.08M

+306.8%

Accounts Receivable

A$6.84M

+17.8%

Inventory

A$0.00

N/A

Long Term Debt

A$130.87K

+71.1%

Short Term Debt

A$32.99K

-81.6%

Return on Assets

-25.63%

N/A

Return on Invested Capital

-37.08%

N/A

Free Cash Flow

A$0.00

+100.0%

Operating Cash Flow

-A$10.62M

-136.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PHYOFIXICO plc

PHYOFIXICO plc$0.07+0.00%

PSYBFPsyBio Therapeutics Corp.

PSYBFPsyBio Therapeutics Corp.$0.00+0.00%

IUGNFImugene Limited

IUGNFImugene Limited$0.09-5.49%

BSEMBioStem Technologies, Inc.

BSEMBioStem Technologies, Inc.$3.94-1.20%

HBPCFHelix BioPharma Corp.

HBPCFHelix BioPharma Corp.$1.71+0.00%

SPHRYStarpharma Holdings Limited

SPHRYStarpharma Holdings Limited$4.76-1.35%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CZRCaesars Entertainment

CZRCaesars Entertainment$29.01+0.01%

NOKNokia

NOKNokia$15.58-0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$38.51-0.02%

SIDUSidus Space

SIDUSidus Space$5.23-0.14%

ATPCAgape Atp

ATPCAgape Atp$6.00+1.11%

IUSBiShares Trust - iShares Core Universal Usd Bond ETF

IUSBiShares Trust - iShares Core Universal Usd Bond ETF$46.15+0.00%

SOFISoFi Technologies

SOFISoFi Technologies$16.79+0.04%

Questions About PRNAF

What is the current price of Alterity Therapeutics?

Alterity Therapeutics is trading at $0.00 per share.

What is the 52-week range for Alterity Therapeutics?

Over the past 52 weeks, Alterity Therapeutics has traded between $0.00 and $0.01.

How much debt does Alterity Therapeutics have?

As of the most recent reporting period, Alterity Therapeutics reported total debt of A$101.88K.

How much cash does Alterity Therapeutics have on hand?

Alterity Therapeutics reported A$21.73M in cash and cash equivalents in its most recent financial results.

What is Alterity Therapeutics’s dividend yield?

Alterity Therapeutics does not currently have a dividend yield.

Alterity Therapeutics

Alterity Therapeutics Financials at a Glance

PRNAF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Alterity Therapeutics

PRNAF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Alterity Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PRNAF

What is the current price of Alterity Therapeutics?

What is the 52-week range for Alterity Therapeutics?

How much debt does Alterity Therapeutics have?

How much cash does Alterity Therapeutics have on hand?

What is Alterity Therapeutics’s dividend yield?

Premium Investing Services